Form 4 for OPRX OptimizeRx Corp
Accepted 2024-06-11 00:00:00 ET · period of report 2024-06-05 · accession 0001628280-24-027714 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-06-11 | 2024-06-05 | OPRX | WASSON GREGORY D | Dir | M - OptEx | $0.00 | +10.1K | 34.0K | +42% | $0 |
| D | 2024-06-11 | 2024-06-07 | OPRX | WASSON GREGORY D | Dir | A - Grant | $0.00 | +13.3K | 47.3K | +39% | $0 |
| D | 2024-06-11 | 2024-06-05 | OPRX | WASSON GREGORY D | Dir | M - OptEx | $0.00 | -10.1K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-05 | M | A | 10,061 | $0.00 | 34,029 | D | — | — | (F1) Restricted stock units convert into common stock on a one-for-one basis. |
| 2 | Common | Common Stock | 2024-06-07 | A | A | 13,286 | $0.00 | 47,315 | D | — | — | (F2) Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in full on the earlier of the first anniversary of the date of grant or the date of the Company's next annual meeting of shareholders. |
| 3 | Derivative | Restricted Stock Units | 2024-06-05 | M | D | 10,061 | $0.00 | 0 | D | — · — to — | 10,061 Common Stock | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F3) On June 7, 2023 the reporting person was granted 10,061 restricted stock units which vested in full on June 5, 2024. |